Beta-Blocker Injection Recalled

Avella of Deer Valley Inc. is recalling 2840 single-use syringes containing labetalol hydrochloride injection solution, 20 mg/4 mL (5 mg per mL), because scannable barcodes on product labels provide incorrect expiration dates that do not match accurate expiration dates listed on the label. The recall was reported in the February 20, 2019, US Food and Drug Administration (FDA) Enforcement Report. 

The recall affects 4-mL syringes (NDC 42852-822-71) repackaged by Avella Specialty Pharmacy from lots 138-20182712@49 (BUD 4/6/19), 138-20182712@63 (BUD 4/6/19), 138-20182712@89 (BUD 4/6/19), 138-20182712@90 (BUD 4/6/19), 138-20182712@93 (BUD 4/6/19), 138-20183112@88 (BUD 4/10/19), 138-20183112@89 (BUD 4/10/19), 138-20183112@91 (BUD 4/10/19), and 138-20190201@96 (BUD 4/12/19).  

The recalled syringes were distributed in Alabama, Arizona, California, Colorado, Florida, Idaho, Michigan, Minnesota, North Carolina, New Jersey, Oregon, Pennsylvania, and Texas. 

Avella of Deer Valley voluntarily initiated the recall February 8, 2019. At press time, the FDA had not yet classified the recall. 

Labetalol hydrochloride injection is used for the urgent treatment of severe high blood pressure.

—Jolynn Tumolo